In today’s briefing:
- KOSPI200 Ad Hoc Index Rebalance: Youlchon Chem to Replace Dongkuk Steel Mill
- Growatt Technology IPO: The Investment Case
- KOSPI 200 Ad-Hoc Changes for Dongkuk Steel Spinoff: Discussing Flow Trading Timeline
- Syngenta Moves $9.4 Billion IPO to Main Board in Shanghai
- Marathon Oil Corporation: Significant Strategic Progress in Equatorial Guinea – Key Drivers
- Albemarle Corporation: Does The Global Expansion Of Lithium Resource & Conversion Capacity Make This A Buy? – Key Drivers
- Morning Views Asia: Medco Energi
KOSPI200 Ad Hoc Index Rebalance: Youlchon Chem to Replace Dongkuk Steel Mill
- Following the spin-off, Dongkuk Steel Mill (001230 KS) will be deleted from the Korea Stock Exchange Kospi 200 Index (KOSPI2 INDEX) and replaced with Youlchon Chemical (008730 KS).
- Youlchon Chemical (008730 KS) just missed being added to the index at the June rebalance but will be added a couple of weeks after the regular rebalance.
- Shorts on Dongkuk Steel Mill (001230 KS) have increased over the last month but overall short interest is way below historical levels.
Growatt Technology IPO: The Investment Case
- Growatt Technology (1833969D CH), a leading PV inverters manufacturer, is pre-marketing a US$400 million HKEx IPO, according to press reports.
- We previously discussed the IPO in Growatt Technology IPO: Growing Watts, Growatt Technology IPO: The Bull Case and Growatt Technology IPO: The Bear Case.
- The updated PHIP which disclosed the 2022 results and latest developments suggests that Growatt continues to deliver profitable and cash-generative growth.
KOSPI 200 Ad-Hoc Changes for Dongkuk Steel Spinoff: Discussing Flow Trading Timeline
- Applying the T+3 relisting date as the effective date will again lead to noteworthy changes to the timeline of rebalancing flow trading.
- It seems unnecessary to concentrate shorting on the trading halt day for Dongkuk Steel. We should aim for price corrections driven by passive flows on the T+2 period before effective.
- Despite the Dongkuk Steel shareholders’ approval on the 12th, Youlchon Chemical’s price experienced a significant decline. The ongoing risk of major shareholder stake sales appears to have overshadowed this event.
Syngenta Moves $9.4 Billion IPO to Main Board in Shanghai
- Swiss agricultural giant Syngenta Group is moving its $9.4 billion initial public offering to the main board of the Shanghai Stock Exchange and dropping a plan to go public on the Nasdaq-like STAR Market, the company said Thursday.
- The unit of Chinese state-owned ChemChina said it made the decision after China fully rolled out its registration-based share issuance system across all boards in February.
- Syngenta Group will be a better fit on the main board, making the stock available to more diversified investors, Syngenta said.
Marathon Oil Corporation: Significant Strategic Progress in Equatorial Guinea – Key Drivers
- It was a successful first quarter for Marathon Oil as it delivered an all-around beat with strong financial and operational performance.
- The company exceeded its commitment to return at least 40% of its cash flow from operations to shareholders, generating strong free cash flow despite not receiving any EG cash dividends.
- First-quarter oil production was consistent with guidance, and the company expects an improving trend in the second and third quarters.
Albemarle Corporation: Does The Global Expansion Of Lithium Resource & Conversion Capacity Make This A Buy? – Key Drivers
- Albemarle had a mixed Q1, with net sales below market expectations though EBITDA was up nearly four times to $1.6 billion resulting in an earnings beat.
- Albemarle selected a site for their U.S.
- Mega-Flex lithium processing facility in Richburg, South Carolina, and announced restructuring their MARBL joint venture in Australia.
Morning Views Asia: Medco Energi
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region, based on key company-specific developments in the past 24 hours. Our Morning Views include a section with a brief market commentary, key market indicators and a macroeconomic and corporate event calendar.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars